To navigate the evolving inhaled and nasal drug delivery industry, pharmaceutical developers need a partner with expertise and next-generation capabilities, from innovative analytical and formulation services to regulatory guidance and commercial supply.
By integrating these services and more under one roof, Holmes Chapel provides expertise across a wide range of platforms and therapy types, connects customers to a collaborative network of partners and demonstrates leadership in the green transition.
In our latest article with ONdrugDelivery, Bespak’s Head of Drug Product Development, Ross Errington, explores the Holmes Chapel site, showcasing the capabilities, expansions and investments helping to support a new era of inhaled and nasal drug-device development.
